MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HEITZ, J. R.
Right arrow Articles by ANDERSON, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HEITZ, J. R.
Right arrow Articles by ANDERSON, B. M.

Molecular Pharmacology, Vol 4, 44-52, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Yeast Alcohol Dehydrogenase by N1-Benzylpyridinium Chlorides

JAMES R. HEITZ 1 and BRUCE M. ANDERSON 1

1 Department of Biochemistry, University of Tennessee, Knoxville, Tennessee 37916

Ten N1-benzylpyridinium chlorides were prepared and studied as inhibitors of the yeast alcohol dehydrogenase-catalyzed oxidation of ethanol. The inhibitors, although containing a variety of functional groups substituted on the pyridinium ring, all inhibited this reaction and in each case the inhibition observed was competitive with respect to NAD+. Interactions of these inhibitors with the "pyridinium ring" region of the NAD+ binding site was suggested by the competitive nature of the inhibition and the simultaneous bintling of all the inhibitors with adenylic acid. Varying the substituent group on the pyridinium ring did not alter significantly the binding properties of the N1-benzyl derivatives except in those cases where charged groups were employed. In comparison to the binding of N1-benzylnicotinamide chloride, N1-benzyl-3-carboxyl-pyridinium chloride was demonstrated to be bound more poorly. N1-Benzyl-3-aminomethylpyridinium chloride, on the other hand, was found to be a better inhibitor than N1-benzylnicotinamide chloride.

Note:
ACKNOWLEDGMENT This is contribution 42 from the Department of Biochemistry, The University of Tennessee. The work was supported by Research Grant AM-08812-03 from the United States Public Health Service.

Submitted on July 19, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics